Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
This systematic review and meta-analysis investigate the efficacy of teprotumumab, a novel monoclonal antibody, in reducing proptosis for patients with long-duration thyroid eye disease (TED). While teprotumumab has shown promise in treating active TED, its effectiveness in chronic cases remained less certain. By synthesizing data from nine individual studies, this meta-analysis aimed to quantify the […]
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
